加巴喷丁预处理对诊室后鼻神经冷冻消融术中疼痛影响的初步报告
本研究为多机构前瞻性分析,纳入26例接受诊室后鼻神经冷冻消融的过敏性/非过敏性鼻炎患者,比较术前1小时口服600mg加巴喷丁与对照组的疼痛视觉模拟评分(VAS)。结果显示加巴喷丁组在术后5、20、30分钟的中位VAS评分均显著低于对照组,表明术前加巴喷丁可显著减轻围手术期不适。
要点
- 术前1小时口服600mg加巴喷丁可显著降低后鼻神经冷冻消融术后5、20、30分钟的疼痛VAS评分。
- 加巴喷丁组与对照组基线鼻部症状总分(TNSS)和迷你鼻结膜炎生活质量问卷(Mini-RQLQ)无显著差异。
- 本研究为初步报告,样本量较小(26例),需更大样本验证。
核心结论
- 术前口服加巴喷丁可显著减轻后鼻神经冷冻消融术后即刻和延迟的患者不适。
研究设计与样本
- 多机构前瞻性分析,纳入2018年3月至2019年4月期间接受诊室后鼻神经冷冻消融的过敏性/非过敏性鼻炎患者26例(加巴喷丁组15例,对照组11例)。
主要发现
- 加巴喷丁组与对照组基线TNSS中位数分别为10(7.5-11.0)和9(6.0-10.0)(p=0.35),基线Mini-RQLQ分别为3.21(2.0-4.0)和2.92(2.78-4.35)(p=0.51)。
- 术后5、20、30分钟加巴喷丁组与对照组的中位VAS疼痛评分分别为0.0(0.0-2.0)vs 3.0(1.0-4.0)、2.0(0.0-3.0)vs 8.0(6.0-10.0)、1.0(0.0-1.0)vs 5.0(4.0-6.0),p值分别为0.02、0.0043、0.003。
临床怎么用
- 对于接受诊室后鼻神经冷冻消融的患者,可考虑术前1小时口服600mg加巴喷丁以减轻围手术期疼痛。
局限性
- 本研究为初步报告,样本量较小(26例),可能影响结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Posterior nasal nerve (PNN) cryoablation is a novel surgical technique to address allergic and nonallergic rhinitis. Periprocedural pain has been reported after PNN cryoablation and there are no standardized protocols for optimal in-office local anesthesia. This study sought to evaluate the effect of gabapentin on patient discomfort following in-office PNN cryoablation. METHODS: Multi-institutional prospective analysis of patients undergoing in-office PNN cryoablation for allergic or nonallergic rhinitis between March 2018 and April 2019. Patients received local anesthesia with or without 600 mg oral gabapentin 1 hour preprocedure. Rhinitis diagnosis, demographics, and baseline disease-specific quality of life (mini-Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ] and Total Nasal Symptom Score [TNSS]) were recorded. Patient discomfort was measured by the pain visual analogue scale (VAS) posttreatment and rated 0 to 10 on an ordinal scale. Fisher's exact and Wilcoxon 2-sample tests were used to evaluate differences between the 2 groups. RESULTS: A total of 26 patients were enrolled (gabapentin n = 15, control = 11). Baseline TNSS scores in the gabapentin vs control group were median [25th percentile to 75th percentile]) 10 (7.5 to 11.0) and 9 (6.0 to 10.0) (p = 0.35). Baseline Mini-RQLQ scores in gabapentin vs control groups were 3.21 (2.0 to 4.0) and 2.92 (2.78 to 4.35) (p = 0.51). The median VAS pain scores at 5, 20, and 30 minutes in the gabapentin vs control group were 0.0 (0.0 to 2.0) vs 3.0 (1.0 to 4.0), 2.0 (0.0 to 3.0) vs 8.0 (6.0 to 10.0), and 1.0 (0.0 to 1.0) vs 5.0 (4.0 to 6.0) (p = 0.02, p = 0.0043, and p = 0.003, respectively). CONCLUSION: Preprocedure gabapentin significantly reduces immediate and delayed postprocedural patient discomfort following PNN cryoablation.
引用
- Steele TO, Hoshal SG, Kim M, et al. A preliminary report on the effect of gabapentin pretreatment on periprocedural pain during in-office posterior nasal nerve cryoablation. Int Forum Allergy Rhinol. 2019. PMID: 31610616. doi:10.1002/alr.22456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。